CapitalG is selling $85.5m of shares in the robotic process automation technology producer as part of an offering sized at almost $1.34bn.

University of Louisville spinout Talaris has filed for an initial public offering on the Nasdaq Global Market.

The CIC-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.

The Fosun-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.

The CN, Goodyear, Kroger, Mando, Navistar, Nvidia, Sina, Traton, Union Pacific, UPS and US Xpress-backed autonomous truck producer was valued at more than $8.5bn in the IPO.

The Fidelity-backed digital banking software provider has floated on the Nasdaq Global Select Market in a $180m offering priced above its range.

The crypto trading platform has executed a direct listing and is now valued above $85bn, six years after BBVA, New York Stock Exchange, NTT Docomo and USAA backed it at a $490m valuation.

The infectious disease drug developer has applied to float in Hong Kong, which will enable the WuXi AppTec-backed 6 Dimensions Capital to exit.

The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.